Key result
Higher platelet-to-lymphocyte ratio is linked to ~22% higher odds of contrast-induced AKI after PCI.
Observational (n=719)
Answers are grounded in this paper and cite their sources.
AIM: There has been a rise in contrast-induced acute kidney injury (CI-AKI). We examined the role of platelet-to-lymphocyte ratio (PLR) in predicting CI-AKI episodes in patients with myocardial infarction (MI) and diabetes. METHODS: A total of 719 patients with diabetes and MI were enrolled. Study population was divided into: group 1 (n = 615) without CI-AKI and group 2 (n = 104) with CI-AKI. RESULTS: Patients with CI-AKI had higher in-hospital mortality and a longer in-hospital stay. Median PLR was higher in patients with CI-AKI. Receiver operating characteristic analysis indicated PLR to be a good predictive tool in assessing the risk of CI-AKI. PLR was an independent predictor of CI-AKI (OR: 1.22; p < 0.0001). CONCLUSION: These results suggest potential role for PLR as a biomarker of CI-AKI among diabetic patients with MI who undergo percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Hudzik et al. (2017) conducted an observational in ST-elevation myocardial infarction and diabetes mellitus (n=719). Platelet-to-lymphocyte ratio (PLR) vs. Patients without contrast-induced acute kidney injury was evaluated on Contrast-induced acute kidney injury (CI-AKI) (OR 1.22, p=<0.0001). Platelet-to-lymphocyte ratio was an independent predictor of contrast-induced acute kidney injury in diabetic STEMI patients undergoing PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: